• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • ResearchMatch (RM)
    • Biomarkers
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Putting A Price On COVID-19 Treatment Remdesivir

Putting A Price On COVID-19 Treatment Remdesivir

by William Jester | May 30, 2020 | Community, Covid, News

Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That’s when most drugs get price tags.  Gilead Sciences, which makes...
Rutgers Leads Clinical Trial of Drug to Prevent Cytokine Storms

Rutgers Leads Clinical Trial of Drug to Prevent Cytokine Storms

by William Jester | May 30, 2020 | Community, Covid, News

Rutgers has launched a clinical trial to test the safety and efficacy of an oral anti-inflammatory drug that could help prevent serious illness and death in early-stage COVID-19 patients. The drug, EDP1815, developed by Evelo Biosciences Inc., will be given to newly...
Rutgers GSE Professor, Alumni Provide Behavioral Resources for Parents and Children

Rutgers GSE Professor, Alumni Provide Behavioral Resources for Parents and Children

by William Jester | May 29, 2020 | Community

Website created to house resources for parents with children struggling with behavior at home. Got a kindergartener who refuses to practice their sight words? An out-of-sorts elementary schooler who’s experiencing nightmares? A middle schooler whose math teacher just...
The time to revisit N.J.’s vaccine law is now

The time to revisit N.J.’s vaccine law is now

by William Jester | May 28, 2020 | Community, News

The New Jersey Legislature postponed a final vote last year on a vaccine bill that would have put an end to religious exemptions from vaccinations for all students enrolled in public and private schools and colleges statewide. The vote occurred against a backdrop of...
AI tool gives doctors a new look at the lungs in treating COVID-19

AI tool gives doctors a new look at the lungs in treating COVID-19

by Pamela Dahlen | May 27, 2020 | Community, Covid, News

Spurred by the COVID-19 pandemic, Princeton researchers have developed a diagnostic tool to analyze chest X-rays for patterns in diseased lungs. The new tool could give doctors valuable information about a patient’s condition, quickly and cheaply, at the point of...
« Older Entries

Recent Posts

  • How a new library is set to transform this underserved N.J. community
  • Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
  • New NJACTS Publication
  • One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
  • Advanced Models Offer Scientists a Promising Tool to Better Understand Brain Disorders

Archives

  • 2025
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,242)
  • Covid (985)
  • CTO Events (6)
  • News (2,857)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.